Page 1 of 1
What’s Next in Preclinical Cancer Immunotherapy Research?
Thursday, March 2, 2023
Sponsor: Crown Bioscience
Partner: Scientist.com
This webinar will include a panel discussion of key topics in the field of cancer immunotherapy, including new and emerging methods, recent publications, and future directions.
Analyzing the Suppressive TME in in Vitro Based Assays
Thursday, January 26, 2023
Sponsor: Crown Bioscience
Partner: Scientist.com
Experts describe suppressive tumor immune microenvironment compartments and patient-derived tissue technologies capable of recapitulating the TME for clinically-relevant studies.
Targeting T Cells Within the Cancer Immunity Cycle
Thursday, December 1, 2022
Sponsor: Crown Bioscience
Partner: Scientist.com
In this webinar, speakers will discuss the role of T cell biology in cancer immunotherapy.
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
Thursday, November 3, 2022
Sponsor: Crown Bioscience
Partner: Scientist.com
Experts provide an overview of ex vivo and in vitro methods, techniques, and model systems for research within the cancer-immunity cycle framework.
Animal Model Selection, Study Design and Current Trends in Preclinical Obesity Research
Wednesday, September 30, 2020
Sponsor: Crown Bioscience
Partner: American Physiological Society
OBESITY SERIES 2020: Dr. Fred Beasley provides an overview of study design, criteria for defining your study aim and expert advice for selecting the ideal rodent model for your preclinical obesity research.
ADA 2020 CrownBio Virtual Event
Friday, June 12, 2020
Sponsor: Crown Bioscience
Explore CrownBio’s virtual American Diabetes Association 2020 event to catch up with the latest preclinical research on diabetes, NAFLD/NASH, obesity, cardiovascular and renal diseases.
Identifying Preclinical Immunotherapy Candidates Using a NHP Exploratory Toxicology Platform
Wednesday, April 8, 2020
Sponsor: Crown Bioscience
Dr. Thomas Scullion discusses how to leverage NHP exploratory toxicology studies to guide and explore lead optimization, dosing paradigms, and future GLP studies.
Reversing Hypertriglyceridemia and Hepatic Steatosis in Dysmetabolic NHPs with a Controlled-Release Mitochondrial Protonophore (CRMP)
Thursday, February 6, 2020
Sponsor: Crown Bioscience
Leigh Goedeke, PhD reviews spontaneous nonhuman primate (NHP) models of NAFLD and metabolic syndrome as a more clinically-relevant preclinical study platform.
Preclinical Obesity Research: Best Practice in Model Selection and Study Design
Thursday, September 12, 2019
Sponsor: Crown Bioscience
Fred Beasley, PhD discusses how to select the most appropriate animal models for your preclinical obesity studies.
How to Optimize Preclinical Diabetes Studies using Stress Free Methods in Non-Human Primates
Wednesday, April 17, 2019
Sponsor: Crown Bioscience
Andrew Puca, PhD discusses techniques for optimizing preclinical diabetes research in spontaneously diabetic NHPs, with a focus on stress free assessments of glucose measurement and response using continuous glucose monitoring and the banana tolerance test.
Page 1 of 1